Gill, Alexander J.
Smith, Matthew D.
Galleguillos, Danny
Garton, Thomas
Mace, Jackson W.
Gadani, Sachin P.
Kumar, Swati
Pokharel, Aayush
Solem, Krista
Potluri, Saahith
Hussein, Omar
Rogines, Giuliana Sardi
Singh, Arihant
Clark, Annatje
Calabresi, Peter A.
Gharagozloo, Marjan
Funding for this research was provided by:
National Multiple Sclerosis Society (FAN-2007-36944, FAN-2106-37832, RG-1907-34756, TA-2104-37423)
NIH (T32 GM136577)
National Institute of Neurological Disorders and Stroke (F31NS132520)
Karen Toffler Charitable Trust (90105789)
R01, NIH (NS041435)
Race to Erase MS (147096)
Article History
Received: 21 August 2024
Accepted: 7 January 2025
First Online: 28 January 2025
Declarations
:
: All experimental protocols were performed in accordance with the National Institutes of Health guidelines for the use of experimental animals and were approved by the Johns Hopkins Institutional Animal Care and Use Committee (protocol # MO22M158).
: Not applicable.
: The authors declare no competing interests.